ZEB1 and malignant colon neoplasm: Liang et al. reported that, in colon cancer cells, upregulated H19 competitively harbors miRNA-138 and miRNA-200a, which hampers the complementary bindings between miRNAs and the mRNAs of Vimentin, ZEB1, and ZEB2.